CDx, cancer and collaborations: Take our reader survey

Drug Discovery News, in collaboration with investment bank Mizuho Securities USA Inc., is conducting a survey on the state of funding and views on companion diagnostics, oncology and pharma.

Amy Swinderman
Drug Discovery News,in collaboration with investment bank Mizuho Securities USA Inc., is conductinga survey on the state of funding and views on companion diagnostics, oncologyand pharma. The goal of this survey is to gain a better understanding ofcurrent and future trends in R&D activity.
 
 
Our web-based survey takes about four to five minutes tocomplete.
 
 
All information will remain confidential, and onlyaggregate, not individual responses nor company names, will be published. Ifyou are interested in receiving a copy of the survey results, please indicatethat at the end of the survey.
 
 
In providing a response to this survey, you represent thatyou have not knowingly disclosed (i) any material non-public information; (ii)any trade secret or other proprietary information; (iii) information which youhave a duty or agreement to keep confidential; or (iv) information obtainedfrom any person expecting such information to be kept confidential or which youbelieve to be confidential.
 

Amy Swinderman

Subscribe to Newsletter
Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

November 2022 Issue Front Cover

Latest Issue  

• Volume 18 • Issue 11 • November 2022

November 2022

November 2022